1. EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
   Mario Cioce et al, 2021, Cancers CrossRef
2. Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells
   Chiara Allocca et al, 2021, Thyroid CrossRef
3. The prognostic value of ephrin type-A2 receptor and Ki-67 in renal cell carcinoma patients
   Iman Mamdouh Talaat et al, 2020, Medicine CrossRef
4. Role of Nuclear Claudin-4 in Renal Cell Carcinoma
   Takuya Owari et al, 2020, International Journal of Molecular Sciences CrossRef
5. Eph/ephrin signaling in the kidney and lower urinary tract
   Anna-Carina Weiss et al, 2016, Pediatric Nephrology CrossRef
6. Treatment of Dutch rat models of glioma using EphrinA1-PE38/GM-CSF chitosan nanoparticles by in situ activation of dendritic cells
   Ming Li et al, 2015, Tumor Biology CrossRef
7. Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
   Hanneke van der Wijngaart et al, 2023, Clinical Proteomics CrossRef
8. Influence of miR‐520e‐mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2
   Jing‐hui Tian et al, 2019, Journal of Viral Hepatitis CrossRef
9. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics
   Yunxia Wang et al, 2023, British Journal of Pharmacology CrossRef